Exco InTouch Unveils New Website and Program for DIA 2013 49th Annual Meeting
Exco InTouch, the leading provider of patient engagement and data capture solutions for clinical research and healthcare providers, has revealed its schedule for DIA 49th Annual Meeting in Boston, Massachusetts, from 24th – 27th June.
Exco InTouch is sending a mix of US and European delegates to DIA, with a strong emphasis on patient-centricity. On booth number 2010 the team will be showcasing its unique mDNA® technology, which increases efficiencies in data management by allowing a truly device independent approach to clinical trials and mHealth programs.
On Thursday 27 June, Director of Clinical Excellence, Judith Teall will give a presentation during the Emerging Electronic Tools in Cardiovascular Outcomes Studies, titled: “Mobile Patient Engagement in CV Outcomes - a two-way process”.
Meanwhile, on Tuesday 25 June Dr Chris Watson, Product Manager at Exco InTouch, will be presenting a poster entitled: “The use of compliant text messaging to increase patient engagement in a study comparing oral contraceptive symptoms”.
Exco InTouch will also unveil its brand new website at DIA, which is designed to be both informative and educational. Featuring a range of infographics, facts and figures about patient engagement and data capture during clinical and late phase trials and mHealth programs, the new website www.excointouch.com showcases Exco InTouch’s ability to engage with patients and capture data using its revolutionary device independent approach.
Ian Jennings, Chief Commercial Officer at Exco InTouch, said: “This is our 6th time at DIA, the flagship event for our industry, and it’s the perfect way to introduce delegates to the work of Exco InTouch. As well as introducing our new website to visitors at Booth 2010, we’ll be demonstrating the versatility of our mDNA® technology and how it can offer secure global mobile services in even the most complex and ever-changing landscapes. Coupled with Judith’s presentation and Chris’s poster, we will give visitors a thorough insight into how our patient engagement and data capture solutions can improve health outcomes.”
The DIA 2013 49th Annual Meeting is the largest multidisciplinary event that brings together a community of professionals at all levels and across all disciplines in the discovery, development, and life cycle management of medical products.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
